Risultati di ricerca
21 giu 2024 · Charterhouse Capital Partners (“Charterhouse”), one of the longest-established private equity firms operating in Europe, today announces its investment in Skin Tech Pharma Group (“Skin Tech”), a leading global medical aesthetics group.
11 giu 2024 · Former NatWest chief executive Alison Rose has joined private equity firm Charterhouse in her first role since leaving the UK high-street lender following the “debanking” of Nigel Farage last...
11 giu 2024 · Former NatWest Group Plc boss Alison Rose has joined private equity firm Charterhouse Capital Partners as a senior adviser, marking her return to the City of London a year after she stepped...
21 giu 2024 · Charterhouse Capital Partners has announced an investment in Skin Tech Pharma Group, a global medical aesthetics group. Skin Tech is a B2B medical aesthetics group that specialises in the production of hyaluronic acid-based injectables, alongside topical peelings, mesotherapy and cosmetic products.
21 giu 2024 · Consumer demand in the medical aesthetics sector has surged due to evolving perceptions of beauty and self-image, along with technological advancements. This shift has also garnered private equity attention. The latest is Charterhouse’s investment in a global medical aesthetics group.
11 giu 2024 · Former NatWest chief executive Alison Rose, who resigned over a scandal linked to debanking Brexit campaigner Nigel Farage last year, has re-emerged as a senior adviser at private equity firm Charterhouse.
21 giu 2024 · Investment Summary. Charterhouse Capital Partners Invests In Skin Tech. On June 21, 2024, private equity firm Charterhouse Capital Partners invested in consumer products company Skin Tech. Investment Highlights. This is Charterhouse Capital Partners’ 4th transaction in the Consumer Products sector.
